Skip to main content
Journal of Feline Medicine and Surgery logoLink to Journal of Feline Medicine and Surgery
. 2014 Dec 22;17(12):979–983. doi: 10.1177/1098612X14563097

Survey of dietary and medication practices of owners of cats with chronic kidney disease

Jessica E Markovich 1,, Lisa M Freeman 1, Mary A Labato 1, Cailin R Heinze 1
PMCID: PMC10816345  PMID: 25535212

Abstract

The objective of this study was to describe the dietary and medication patterns of cats with chronic kidney disease (CKD). In this prospective, cross-sectional descriptive study, owners of cats with CKD were asked to complete a web-based survey. The study was advertised on CKD-, pet-, veterinary- and breed-associated websites and list serves. Owners of 1089 cats with CKD participated in the study. The mean reported age of the cats with CKD was 13.7 ± 4.2 years. Forty percent (430/1089) of cats had concurrent diseases, with hyperthyroidism, heart disease and inflammatory bowel disease being the most common. Veterinarian recommendation was the most common reason reported (684/1032; 66%) for diet selection, and 51% (556/1089) of owners fed a veterinary therapeutic diet formulated for kidney disease as some component of the diet. Many owners (466/1079; 43%) reported that their cats had an abnormal appetite; of these owners, 52% responded that their cats had a poor appetite or required coaxing to eat 5–7 days per week. Forty-seven percent and 51% of cats were receiving subcutaneous fluids and oral medications, respectively; however, most cats (811/1036; 78%) were not receiving phosphorus-binding medications. Fifty-six percent and 38% of cats received commercial cat treats and dietary supplements, respectively. Anorexia or hyporexia is a common problem in cats with CKD and may lead to cats being fed suboptimal diets for their disease. This information may be useful for treating or designing nutritional studies for cats with CKD.

Introduction

Chronic kidney disease (CKD) is a common systemic disease affecting cats. Clinical studies have demonstrated the importance of dietary management in slowing the progression of CKD in the cat.13 Previous studies have indicated that the overall number of owners who are actively feeding veterinary diets ranges from only 12–21% of animals with various medical conditions.4,5 However, specific data as to the prevalence of owners of cats with CKD feeding veterinary diets formulated for kidney disease are lacking in the literature.

Common clinical signs associated with CKD are decreased appetite, halitosis, dull hair coat, polyuria/polydipsia and weight loss.6,7 There is a large variety of medications and dietary supplements recommended for treatment of CKD available commercially, but there is very little information as to the frequency of dietary supplement administration by owners of cats with CKD. In humans, the number of pills one takes (ie, pill burden) affects quality of life, as well as the likelihood of compliance with physician recommendations. 8 This may be an even more important issue in cats given the difficulty of medicating many cats and the option of euthanasia. In cats and dogs with heart disease, owners typically prefer quality of life to quantity of life.9,10 Therefore, pill burden, with regard to both medications and dietary supplements, of the cat with CKD is an important question.

Finally, the issue of decreased or altered appetite in cats is another common and important consideration. While the role of anorexia in euthanasia of cats has not been reported, one study in dogs with congestive heart failure showed anorexia to be one of the most common clinical signs contributing to an owner’s decision for euthanasia. 11 Information on these issues is important to gain a better understanding of how cat owners care for their cats with CKD and how to better communicate with owners. In addition, it would be useful information to be able to better design studies evaluating nutrition in cats with CKD. To answer these questions, the objective of this study was to describe the dietary and medication patterns of cats with CKD, as well as the prevalence of anorexia and concurrent diseases.

Materials and methods

A web-based survey was designed, with the assistance of the Tufts University Office for Institutional Research and Evaluation, consisting of 33 questions evaluating CKD, diet, use of supplements and medication history. The survey was advertised to owners of cats with CKD on online cat-owner support groups, social media (eg, Facebook, PetFinder, Craig’s List) and breeder websites. The survey was also advertised directly to veterinarians via email and published advertisements. The survey was posted online for 6 weeks for public participation. In order to participate in this survey, owners were required to be 18 years of age or older and own a cat with CKD. Owners with more than one cat could complete the survey more than once but each survey provided information on a single cat. No incentive was offered for participation in the survey, and all responses were anonymous. Owners were asked about their cat’s most recent creatinine value and, based on their reported values, IRIS stage was estimated. 12 The majority of the questions were multiple choice or short-answer in design, although one of the questions on appetite was a visual analog scale. Short answers from the owners were evaluated and grouped according to the similarity of their contents. Each survey required 10–15 mins to complete. This study was approved by the Tufts University Institutional Review Board.

Statistical analysis

Data were examined graphically. Data are presented as mean ± SD (normally distributed data) or median and range (skewed data). Descriptive data are reported as actual counts and the percentage of respondents that answered that individual question (ie, the actual count divided by the total number of respondents that answered that individual question). However, for some questions, respondents could provide more than one answer (eg, ‘Do you give any of the following medications to your cat?’, and could check any number of 12 different medications). For these types of questions, the total number of respondents for that question could not be determined. Therefore, only the actual count for responses is provided. Descriptive data were calculated using Systat 13.0 (Systat, Chicago, IL, USA).

Results

Signalment and environmental information

Completed surveys were recorded from 1089 respondents. Thirty-five breeds were represented in this study. The most common breeds were domestic short- and longhair (836/1088; 77%), followed by Siamese (61/1088; 6%), Persian (29/1088; 3%) and Maine Coon (25/1088; 2%). The mean age of all cats was 13.7 ± 4.2 years.

Most owners (870/1086; 80%) reported that their cat was kept indoors only, while 211 (19%) cats were indoor/outdoor and five (1%) owners reported that their cat was kept entirely outdoors. The majority of owners (754/1087; 69%) had multi-cat households (one additional cat [n = 284], two additional cats [n = 187], three or more additional cats [n = 283]). Fifty percent of owners (516/1033) reported living in a suburban environment, whereas 28% (291) reported living in an urban environment and 22% (226) reported a rural environment.

Medical history

The questionnaire asked owners about their cat’s most recent creatinine value: only 626/1083 (58%) owners were able to report this value. Based on their reported values, 34/626 (5%) were classified as IRIS stage 1, 238 (38%) were in IRIS stage 2, 234 (37%) were in IRIS stage 3 and 120 (19%) were in IRIS stage 4. Two hundred and forty-five of 1083 owners (23%) reported that their cat had never had a urinalysis performed. Forty percent (430/1089) of cats were reported by the owners to have a concurrent disease. Hyperthyroidism (120/1089; 11%) was the most commonly reported concurrent disease, followed by heart disease (85; 8%), inflammatory bowel disease (70; 6%), diabetes mellitus (47; 4%), neoplasia (35; 3%) and hypertension (31; 3%). Some cats had multiple concurrent diseases.

Appetite

Forty-three percent (466/1079) of respondents reported that their cat had an abnormal appetite. For these cats, owners reported having to coax their cat to eat 1–2 days per week (102/432; 24%), 3–4 days per week (106/432; 25%) and 5–7 days per week (224/432; 52%). Feeding frequency varied from having food always available (505/1088; 46%), feeding once daily (20/1088; 2%), feeding twice daily (233/1088; 21%) and feeding three or more times daily (330/1088; 30%)

Dietary history

Many owners (444/1082; 41%) reported feeding a mixture of canned and dry foods, while 20% (212/1082) fed all dry, 31% (339/1082) fed all canned, 2% (25/1082) fed a home-cooked diet and 6% (62/1082) fed other types of diets, including raw, as the primary food type. At least one veterinary therapeutic diet formulated for kidney disease was included as part of the diet for 556/1089 cats (51%). Of those cats that were eating veterinary therapeutic diets designed for CKD, 77% (428/556) ate one brand, 17% (96/556) alternated between two brands and 6% (32/556) alternated between three or more brands. By contrast, 156/1089 cats (14%) ate veterinary therapeutic diets not intended for CKD. For the cats eating veterinary therapeutic diets not intended for CKD, the most commonly reported diets were those intended for lower urinary tract disease (24/156; 15%) and diets intended for cats with adverse food reactions (13/156; 8%). Fifty-one percent (556/1089) of owners reported feeding an over-the-counter commercial diet, either as a sole diet or in combination with a veterinary therapeutic diet. Many owners also reported feeding other diet types in addition to the primary diet: home-cooked diets (102/1089; 9%) and raw meat-based diets (44/1089; 4%).

Most owners (607/1084; 56%) reported giving commercial treats to their cat. The number of treats given each week ranged from one to more than six, with nearly half of owners giving greater than six treats per week (226/474; 48%).

Owners were asked for the resource used most commonly for dietary recommendations for their cat. The most commonly reported resource was veterinarians (684/1032; 66%), followed by internet resources (260/1032; 25%), pet stores (50/1032; 5%), friends (30/1032; 3%) and breeders (8/1032; 1%).

Medication and supplement administration

Four hundred and sixteen of 1087 (38%) owners reported administering vitamins, minerals or other dietary supplements to their cat. B vitamins were the most common supplement administered (160/416; 38%), followed by fatty acids (123; 30%), joint supplements (117; 28%), a symbiotic (Azodyl; Vétoquinol USA) (ie, a prebiotic plus a probiotic; 83 [20%]) and multi-vitamins (74; 18%).

Five hundred and eleven of the owners were administering subcutaneous fluids to their cats. The most common oral medications included famotidine (n = 298), phosphorus-binding medications (n = 225) and angiotensin-converting enzyme inhibitors (n = 90). The most common type of phosphorus binder administered was aluminum hydroxide (143/225; 64%), followed by calcium-based phosphorus binders (71/225; 32%). For owners administering any oral medications to their cat (550/1089; 51%), the median number of medications administered was two per day (range 0–10). Most owners administered oral medications directly in their cat’s mouth (n = 459), followed by crushing the medication and mixing it in the cat’s food (n = 219), having the medications compounded into a liquid or flavored treat (n = 144), giving it in a treat designed to hold a pill (Pill Pocket; The Nutro Company) (n = 125) or giving the medication in human foods (n = 38).

Owner demographics

Owners were from 48 states (plus Washington, DC, and Puerto Rico) and 33 countries. The majority of owners were female (902/1045; 86%) and resided in the USA (714/1089; 66%). Most respondents (777/1035; 75%) held a bachelor’s degree or above. Veterinarians and veterinary technicians represented 9% (91/1035) of all respondents, whereas cat breeders represented 1% (14/1035).

Discussion

The majority of owners in this study were feeding a therapeutic diet formulated for kidney disease; however, it was frequently in combination with other commercial canned or dry diets or, less frequently, raw or home-cooked diets, so the therapeutic diet often only comprised a portion of the overall diet. Although veterinary therapeutic diets formulated for CKD have been associated with a longer survival time in some studies, these studies evaluated cats solely or primarily eating the veterinary therapeutic diet.13 Veterinary therapeutic diets formulated specifically for CKD are likely to be less beneficial when fed only as a portion of the diet, particularly if the remainder of the diet has undesirable properties for a cat with CKD (eg, high phosphorus, raw-meat based diet, unbalanced home-cooked diet). 13 These results demonstrate the importance of obtaining a complete diet history at every visit for cats with CKD to determine what additional foods are being provided to the cat to ensure that the overall diet is optimized.14,15

Anorexia (loss of appetite), hyporexia (reduced calorie intake) and alterations in food preferences were reported by 43% of owners of cats with CKD in the current study. Decreased appetite has been shown in multiple studies to be used by pet owners as an indication of quality of life for both cats and dogs.911 This owner perception may be reflected in the current study by the large percentage (76%) of owners that either had food available to the cat all of the time or fed their cat three or more times per day, as well as the large variety of foods offered to many of the cats. Persistent alterations in appetite likely contribute to owners providing foods to their cat that are not ideal for the management of CKD, or are nutritionally unbalanced, in an attempt to encourage food consumption. Although not evaluated in the current study, the common finding of anorexia, hyporexia and alterations in food intake suggest that early use of feeding tubes may allow for better medical and nutritional management in the cat with CKD.

Dietary supplements were administered to 38% of the cats in this study. This figure is higher than that reported in previous studies of both healthy cats (10%) 5 and those with cardiac disease (13%). 16 This may reflect the true percentage of owners administering supplements to their cats with CKD or may be the result of bias of owners who chose to participate in the survey. Nonetheless, efficacy and safety of administration for most dietary supplements has not been established. Clinicians should enquire as to the administration of supplements as part of the complete diet history for every cat, as interactions between these products and medications may occur and can be difficult to diagnose in the chronically ill cat. Furthermore, the administration of some supplements may contribute to anorexia or hyporexia. Finally, the impact of these products upon the underlying disease in cats with CKD has not been evaluated. In one survey of humans diagnosed with CKD, 8% were unknowingly taking a supplement that could be harmful to the kidneys, many in the form of multi-vitamins that contained potentially harmful herbs. 17 Further studies are needed in cats with CKD in order to ensure that the administration of dietary supplements is not having adverse effects in cats with CKD.

Phosphorus is the nutrient that has been most consistently linked to the progression of CKD in cats.1820 As kidney disease progresses, dietary phosphorus restriction is no longer sufficient to maintain serum phosphorus concentrations in an acceptable range, and phosphate binders are required. Only 22% (225/1036) of owners in the current study reported that they administered phosphorus binders to their cat. While it is unknown how many of the cats in the current study had hyperphosphatemia, this would be useful information in future studies in order to determine the percentage of cats that have indications for receiving binders that actually are receiving them.

Concurrent diseases were common in the current study, with 40% of all cats having one or more concurrent diseases. The most common concurrent disease was hyperthyroidism, and this association has also been reported in a recent study. 21 Both CKD and hyperthyroidism are common in geriatric cats, and the treatment of hyperthyroidism can decrease the glomerular filtration rate and unmask underlying kidney disease. Heart disease was reported in 8% of the cats and was the second most commonly reported disease in this study, which is less than the reported prevalence rates of 10–15% in several studies of cats.22,23 This may be the result of the fact that the prevalence in the current study is based on owner-reported presence of disease and some cats may have had occult heart disease that had not been identified if the cat had not undergone echocardiography. Similarly, the prevalence of hypertension in the current study was far below that of the 30% reported in a previous study. 24 The prevalence of hypertension may be limited by the owners being unaware of blood pressure results, blood pressure measurements not being routinely performed in all practices, or a true lower prevalence when compared with the previous study.

Pill administration in any cat, but particularly in the hyporectic or anorectic cat, can be a challenge. The majority of owners in this study reported administering medications directly into their cat’s mouth, which is consistent with a recent study of owners of cats with hyperthyroidism. 21 However, the second most common method was mixing the pills with food, which may contribute to the high prevalence of decreased appetite reported by owners in this study as administering medications or supplements in the cat’s food can cause a food aversion in some cats. Many more owners in the current study reported directly pilling the cat compared with a previous study of cats with heart disease. 16 In that study, a larger percentage (34%) of cats were given pills in table foods. Clinicians should question owners as to the ease of medication administration and offer appropriate options if they are unable to pill the cat without food. Ensuring that the foods or treats used to administer pills are appropriate for CKD is also important in order to optimize the overall diet plan.

Limitations to this study include the intrinsic biases present in an owner-reported survey, such as the owners who chose to participate in the survey, the reliance on their reported information (eg, they may under- or over-report certain diseases), and the subjective state of the information reported (eg, creatinine, phosphorus or urinalysis results from owner recall rather than review of medical records). In addition, IRIS classification was based on owner-reported values so may not be accurate. This study is unique in the wide geographical distribution of owners of cats with CKD; however, no attempt was made to differentiate regional effects within these data. There may be regional effects within the USA on medical and nutritional practices, and also potential differences among different countries. Finally, only the behaviors reported by the cat owners responding to the survey could be assessed, and it is not possible to determine whether the owners’ practices deviated from recommendations by the veterinarian. The issue of adherence is an important one, and would be useful to address in future studies.

Conclusions

CKD remains one of the most commonly diagnosed diseases in the cat. Results of the current study demonstrate that there is wide variation in the medication and nutritional practices used in cats with CKD, with not all being optimal. A thorough dietary history, including the specific diet(s), treats, table food, supplements and medication administration, is an integral component to the management of the cat with CKD.14,15 This information can aid the clinician in their communications with owners and also with researchers concerning design of future studies regarding the cat with CKD.

Footnotes

Presented, in part, at the 2013 American College of Veterinary Internal Medicine Forum, Seattle, WA, USA, 12–15 June 2013

The authors do not have any potential conflicts of interest to declare.

Funding: Supported by the Tufts Renfroe Renal Research Fund. Dr Markovich’s residency was funded by VCA Antech, Inc.

Accepted: 17 November 2014

References

  • 1. Elliott J, Rawlings JM, Markwell PJ, et al. Survival of cats with naturally occurring chronic renal failure: effect of dietary management. J Small Anim Pract 2000; 41: 235–242. [DOI] [PubMed] [Google Scholar]
  • 2. Plantinga EA, Everts H, Kastelein AMC, et al. Retrospective study of the survival of cats with acquired chronic renal insufficiency offered different commercial diets. Vet Rec 2005; 157: 185–187. [DOI] [PubMed] [Google Scholar]
  • 3. Ross SJ, Osborne CA, Kirk CA, et al. Clinical evaluation of dietary modification for treatment of spontaneous chronic kidney disease in cats. J Am Vet Med Assoc 2006; 229: 949–957. [DOI] [PubMed] [Google Scholar]
  • 4. American Animal Hospital Association. Compliance. Taking quality care to the next level. http://secure.aahanet.org/eweb/images/student/pdf/Compliance.pdf (2009, accessed October 7, 2013).
  • 5. Freeman LM, Abood SK, Fascetti AJ, et al. Disease prevalence among dogs and cats in the United States and Australia and proportions of dogs and cats that receive therapeutic diets or dietary supplements. J Am Vet Med Assoc 2006; 229: 531–534. [DOI] [PubMed] [Google Scholar]
  • 6. King JN, Tasker S, Gunn-Moore DA, et al. Prognostic factors in cats with chronic kidney disease. J Vet Intern Med 2007; 21: 906–916. [PubMed] [Google Scholar]
  • 7. Polzin DJ. Chronic kidney disease. In: Ettinger SJ, Feldman EC. (eds). Textbook of veterinary internal medicine, 7th ed. St Louis, MO: Saunders Elsevier, 2010, pp 1990–2021. [Google Scholar]
  • 8. Chiu YW, Teitelbaum I, Misra M, et al. Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients. Clin J Am Soc Nephrol 2009; 4: 1089–1096. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Oyama MA, Rush JE, O’Sullivan ML, et al. Perceptions and priorities of owners of dogs with heart disease regarding quality versus quantity of life for their pets. J Am Vet Med Assoc 2008; 233: 104–108. [DOI] [PubMed] [Google Scholar]
  • 10. Reynolds CA, Oyama MA, Rush JE, et al. Perceptions of quality of life and priorities of owners of cats with heart disease. J Vet Intern Med 2010; 24: 1421–1426. [DOI] [PubMed] [Google Scholar]
  • 11. Mallery KF, Freeman LM, Harpster NK, et al. Factors contributing to the decision for euthanasia of dogs with congestive heart failure. J Am Vet Med Assoc 1999; 214: 1201–1204. [PubMed] [Google Scholar]
  • 12. International Renal Interest Society. IRIS 2009 staging of CKD. http://iris-kidney.com/guidelines/en/staging_ckd.shtml (accessed October 7, 2013).
  • 13. Larsen JA, Parks EM, Heinze CR, et al. Evaluation of recipes for home-prepared diets for dogs and cats with chronic kidney disease. J Am Vet Med Assoc 2012; 240: 532–538. [DOI] [PubMed] [Google Scholar]
  • 14. Baldwin K, Bartges J, Buffington T, et al. AAHA Nutritional assessment guidelines for dogs and cats. J Am Anim Hosp Assoc 2010; 46: 285–296. [DOI] [PubMed] [Google Scholar]
  • 15. WSAVA Nutritional Assessment Guidelines Task Force Members, Freeman L, Becvarova I, et al. WSAVA nutritional assessment guidelines. J Small Anim Pract 2011; 52: 385–396. [DOI] [PubMed] [Google Scholar]
  • 16. Torin DS, Freeman LM, Rush JE. Dietary patterns of cats with cardiac disease. J Am Vet Med Assoc 2007; 230: 862–867. [DOI] [PubMed] [Google Scholar]
  • 17. Grubbs V, Plantinga LC, Tuot DS, et al. Americans’ use of dietary supplements that are potentially harmful in CKD. Am J Kidney Dis 2013; 61: 739–747. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 18. Ross LA, Finco DR, Crowell WA. Effect of dietary phosphorus restriction on the kidneys of cats with reduced renal mass. Am J Vet Res 1982; 43: 1023–1026. [PubMed] [Google Scholar]
  • 19. Barber PJ, Rawlings JM, Markwell PJ, et al. Effect of dietary phosphate restriction on renal secondary hyperparathyroidism in the cat. J Small Anim Pract 1999; 40: 62–70. [DOI] [PubMed] [Google Scholar]
  • 20. Geddes RF, Finch NC, Syme HM, et al. The role of phosphorus in the pathophysiology of chronic kidney disease. J Vet Emerg Crit Care 2013; 23: 122–133. [DOI] [PubMed] [Google Scholar]
  • 21. Caney SMA. An online survey to determine owner experiences and opinions on the management of their hyperthyroid cats using anti-thyroid medications. J Feline Med Surg 2013; 15: 494–502. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Cote E, Manning AM, Emerson D, et al. Assessment of heart murmurs in overtly healthy cats. J Am Vet Med Assoc 2004; 225: 384–388. [DOI] [PubMed] [Google Scholar]
  • 23. Paige CF, Abbott JA, Elvinger F, et al. Prevalence of cardiomyopathy in apparently healthy cats. J Am Vet Med Assoc 2009; 234: 1398–1403. [DOI] [PubMed] [Google Scholar]
  • 24. Syme HM, Markwell PJ, Pfeiffer D, et al. Survival of cats with naturally occurring chronic renal failure is related to severity of proteinuria. J Vet Intern Med 2006; 20: 528–535. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Feline Medicine and Surgery are provided here courtesy of SAGE Publications

RESOURCES